US 9820966
Stabilized statin formulations
granted A61KA61K31/40A61K47/40
Quick answer
US patent 9820966 (Stabilized statin formulations) held by Cumberland Pharmaceuticals Inc. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/40, A61K47/40, A61K47/6951, A61K9/0019